Currently, BPC-157 is not classified as a controlled substance, and standard drug panels (such as those screening for narcotics, cannabinoids, or anabolic steroids) do not typically test for peptides like BPC-157

Common causes: MTHFR gene mutations (C677T, A1298C) reducing enzyme efficiency Vitamin B deficiencies (folate, B12, B6) preventing homocysteine recycling Kidney disease impairing homocysteine clearance Certain medications (methotrexate, antacids, metformin) Hypothyroidism Aging Health risks associated with high homocysteine: Cardiovascular disease damages blood vessel walls, promotes atherosclerosis Blood clots increases risk of DVT, pulmonary embolism, stroke Heart attack and stroke particularly when levels exceed 15 mol/L Pregnancy complications miscarriage, preeclampsia, neural tube defects Cognitive decline Alzheimers disease, dementia, memory problems Osteoporosis weakens bone structure Depression and mental health issues Treatment approach: Increase methylated B vitamins (methylfolate, methyl-B12, B6) Improve diet with folate-rich foods Address underlying deficiencies Support methylation pathways Monitor and reduce levels to optimal range (below 10 mol/L) The goal: Lower homocysteine by improving your bodys ability to process it efficiently

This is particularly relevant for plantar fasciitis, as the condition often involves inflammation at the calcaneal attachment point where the fascia connects to the heel bone
Lifestyle Factors Habits that may support healthy growth-hormone output alongside the protocol
BPC-157 is a synthetic peptide based on a natural compound found in the stomach